Despite significant advances in prevention, diagnosis and treatment since then, TB is now the world’s deadliest infectious disease, claiming over 1.6 million lives and newly infecting an estimated 10 million people every year.

Nearly 1.7 billion people – around a quarter of the world’s population – have latent TB infection; without intervention, up to 10% of these individuals could develop active TB during their lifetime. Alarmingly, the emergence of drug-resistant TB (DR-TB) is threatening hard-won gains. DR-TB is now estimated to be responsible for one-third of all deaths due to antimicrobial resistance (AMR).

The PSC is a diverse coalition of 60+ companies from around the world committed to ending TB by 2030 in partnership with others. The PSC aims to leverage private sector knowledge, capabilities, and commitments towards ending TB through individual and collective action along the care pathway; raising awareness about TB and its impact on people and communities; improving collaboration between the public and private sectors; and shaping global strategies by actively engaging and contributing unique perspectives in the Stop TB Partnership.

For more information on the Stop TB Partnership, visit: www.stoptb.org.